SEC Tracker
Get the app

Fate Therapeutics FATE

Fate filed S-3 for $300M offering

Securities offering

Form
S-3
Filed
Importance
Routine
  1. Up to $300M in securities offered
  2. Common stock up to $100M
  3. Replacement for prior S-3 effective 2023

Written from the S-3 on EDGAR. AI can make mistakes. Check the filing.

Open in the appGet the appView on EDGAR

Get an email when Fate Therapeutics files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2836 and related industry codes: the same peer list as the financial tables.

  1. Protalix BioTherapeutics PLX public float $113M, Jun 30, 2025
  2. Caribou Biosciences CRBU public float $113M, Jun 30, 2025
  3. Protara Therapeutics PRTO public float $112M, Jun 30, 2025
  4. TuHURA Biosciences HURA public float $111M, Jun 30, 2025
  5. Alector ALEC public float $115M, Jun 30, 2025

Data on this page was fetched . The filing on SEC.gov is the record.